Top of the Morning Podcast Por Mint - HT Smartcast arte de portada

Top of the Morning

Top of the Morning

De: Mint - HT Smartcast
Escúchala gratis

Acerca de esta escucha

 Top of the Morning is a daily podcast hosted by Nelson John, in which we bring you all the action from the global markets and the business world to kick-start your day on a well-informed note. This is a Mint production, brought to you by HT Smartcast Economía Finanzas Personales Política y Gobierno
Episodios
  • Airtel, Tata & Hero - Earnings Overview | IND-US, Tariff Tensions Simmer Again

    Airtel, Tata & Hero - Earnings Overview | IND-US, Tariff Tensions Simmer Again
    May 14 2025
    India vs. US: Trade Tensions Heat UpIndia is ready to hit back with $1.91 billion in tariffs on key US goods—like almonds, petrochemicals, and medical devices—if steel and aluminium duties aren’t withdrawn by June 8. The trigger? Trump’s extension of safeguard duties. Commerce Minister Piyush Goyal heads to Washington on May 16 to try and broker a deal. With $7.6B in exports on the line and a 90-day tariff pause set to expire on July 8, India’s playing hardball while still betting on a Free Trade Agreement. Airtel’s Q4 Rings Loud Bharti Airtel posted a stunning 432% jump in Q4FY25 net profit at ₹11,022 crore, riding high on tariff hikes and a one-time tax gain. Revenue rose 27% to ₹47,876 crore, while ARPU hit ₹245. With 590.5 million users, the company also sealed a satellite internet pact with Elon Musk’s Starlink. A ₹16/share final dividend caps off a blockbuster year. Tata’s Mixed Drive Tata Motors saw Q4 profit drop 51% YoY to ₹8,470 crore, but FY25 revenue hit a record ₹4.39 lakh crore. JLR’s PBT soared to a decade-high £2.5 billion, and Tata’s EV arm turned EBITDA positive. Challenges persist in passenger vehicles, but the company remains debt-free and optimistic. A ₹6 dividend and a key Investor Day on June 16 are on the radar. Hero’s Global EV Push Hero MotoCorp’s FY25 net profit rose 16% to ₹4,610 crore. Exports jumped 44%, and EV sales rocketed 175%, with its Vida brand doubling market share. But rivals like Honda and TVS are growing faster. Hero plans European expansion and is betting big on EVs and new three-wheeler plays via Euler Motors. Cipla Steady Amid Policy Storm Cipla shrugged off US pharma tariff fears and posted a 30% jump in Q4 profit to ₹1,222 crore. FY25 revenue grew 8% to ₹27,548 crore. The US remains key, now forming 29% of revenue, while India remains the long-term play. With GLP-1 drugs like Ozempic going off patent soon, Cipla’s gearing up with in-house and partner products for the next leg of growth.
    Más Menos
    8 m
  • Bulls Break Loose | Yes Bank – SMBC Deal | Worldline Exit from India

    Bulls Break Loose | Yes Bank – SMBC Deal | Worldline Exit from India
    May 13 2025
    Market Roars Back: Ceasefire & Tariff Pause Spark ₹16 Trillion RallyPeace on the borders and a tariff truce overseas gave Indian markets their best day in over four years. With India-Pakistan tensions cooling and US-China easing trade friction, the Nifty soared 3.8% and Sensex jumped 3.7%, adding ₹16 trillion to investor wealth. IT, banking, and blue-chip stocks led the charge, as FIIs and DIIs poured in over ₹2,600 crore. “We’re in a sweet spot,” said Marcellus’ Saurabh Mukherjea, flagging optimism ahead of earnings and a potential EM bull run in 2025. Trump’s Drug Price Bombshell Rattles Indian Pharma Donald Trump’s executive order to slash US prescription drug prices by 59% has stirred unease among Indian pharma exporters. Branded drugmakers like Sun Pharma, with up to 17% US revenue exposure, face risks if the rule is enforced. Generic manufacturers may escape unscathed—for now. With Trump pushing for price parity with Europe, and past efforts blocked in court, Indian pharma must brace for policy volatility in its top export market. Yes Bank’s SMBC Deal Signals Fresh Start Yes Bank is readying for a reset with a ₹13,482 crore lifeline from Japan’s SMBC, which will pick up a 20% stake. CEO Prashant Kumar called it a triple win: reducing SBI’s stake overhang, onboarding a global strategic partner, and potentially securing a credit rating upgrade. With PE options ruled out and M&A off the table, the bank is betting on stability, not survival. Approval is expected by September, as analysts cautiously back the move. Worldline Looks to Exit India in $200M Deal French fintech Worldline is quietly preparing to exit India, hiring BNP Paribas to find a buyer for its B2B payments business. The move is part of CEO Pierre Vacheron’s cost-cutting and portfolio-pruning turnaround plan following steep losses and multiple profit warnings. Razorpay and PayU are seen as front-runners. If it goes through, the deal could reshape India’s digital payments battlefield—and help Worldline reset focus on core markets. Hero’s Pivot Moment: Munjal Returns Amid EV PressureLeadership churn at Hero MotoCorp has brought 71-year-old Pawan Munjal back into the spotlight. With CEO Niranjan Gupta exiting and Honda closing in on sales, India’s two-wheeler giant is in reset mode. Interim CEO Vikram Kasbekar steps in as the company struggles with slow EV adoption and a 4.5% YTD stock drop. With just 48,674 EV scooters sold versus TVS and Bajaj’s 2 lakh+, Munjal’s next move will be critical. Investors await Tuesday’s earnings for clues on Hero’s growth, margins, and roadmap.
    Más Menos
    8 m
  • Kashmir - Trump Talks. India Walks | Sensex Sinks on Border Heat | Op Sindoor - 10 Takeaways

    Kashmir - Trump Talks. India Walks | Sensex Sinks on Border Heat | Op Sindoor - 10 Takeaways
    May 12 2025
    Operation Sindoor: “We Struck Where It Hurt”India’s top military brass revealed the impact of Operation Sindoor, launched after the April 22 Pahalgam terror attack. Air Marshal AK Bharti said strikes targeted key Pakistani airbases like Chaklala and Rahim Yar Khan. Over 100 terrorists, including high-value targets like IC-814 hijacker Yusuf Azhar, were eliminated. India also lost five defence personnel. Despite a brief ceasefire request by Pakistan via hotline, violations resumed within hours, including drone attacks and civilian targeting. India made it clear—further provocations will be met with decisive force. D-Street Wobbles Amid Border HeatIndia’s longest stock market rally of 2025 came to a halt as border tensions rattled investors. The Sensex dropped 1,047 points, Nifty fell 339, and Bank Nifty slid 2.76%. Most sectors ended in the red, with realty, banking, and pharma leading the decline. Analysts warn of more correction ahead, with key support at 23,800. With volatility high and geopolitical risk rising, experts advise a cautious, stock-specific approach for the coming week. BrahMos Facility Inaugurated in LucknowDefence Minister Rajnath Singh inaugurated a new 200-acre BrahMos missile facility in Lucknow, linking it to India’s renewed defence posture under Operation Sindoor. Part of the UP Defence Corridor, the facility underscores India’s push for self-reliance in military tech, with ₹34,000 crore in investment proposals already. Singh reiterated India’s intent to neutralize terrorism with precision, calling the strikes a message of strength. UP CM Yogi Adityanath echoed that India would now “crush terrorism, not tolerate it.” India Rejects Trump’s Kashmir OfferIndia firmly rejected U.S. President Donald Trump’s offer to mediate on Kashmir. Trump, who inaccurately referred to it as a “thousand-year conflict,” claimed credit for brokering a ceasefire. India dismissed the idea, reiterating that Jammu & Kashmir is a bilateral issue and the only matter worth discussing is the return of Pakistan-occupied Kashmir. While Pakistan welcomed Trump’s remarks, India’s position remains unchanged—no third-party mediation. Combat Medicine Stock-Up BeginsWith conflict risks rising, India is scaling up production of combat medicines. The Health Ministry, led by J.P. Nadda, has directed the Department of Pharmaceuticals to boost supplies of trauma essentials—antibiotics, burn treatments, orthopedic implants, and blood products. A 24x7 control center is being established to coordinate emergency response. Doctors warn that war-related injuries demand fast access to life-saving supplies, and India’s health sector is quietly shifting into battle readiness mode.
    Más Menos
    8 m
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones